Dr Katie Morrisroe
Honorary Clinical Associate Fellow
Department of Medicine
117 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Proportions of patients meeting definitions for progressive disease or improvement should be included in clinical trials for systemic sclerosis interstitial lung disease
DOI: 10.1186/s13075-026-03803-z2026
Journal article
Prevalence and Risk Factors for Esophageal Strictures in Systemic Sclerosis
DOI: 10.1002/acr2.900332026
Journal article
Evaluation of a screening algorithm to detect systemic sclerosis-related myopathy
DOI: 10.1093/rheumatology/keaf6882026
Journal article
Associations with, and predictors of, progression in systemic sclerosis-related interstitial lung disease: a scoping literature review
DOI: 10.1183/16000617.0273-20242026
Journal article
Author Correction: Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases (Nature Reviews Rheumatology, (2025), 21, 3, (137-156), 10.1038/s41584-024-01216-3)
DOI: 10.1038/s41584-025-01331-92025
Journal article
Predictors and prognosis of pulmonary hypertension complicating interstitial lung disease in systemic sclerosis
DOI: 10.1093/rheumatology/keae1662021
Research grants (ARC, NHMRC, MRFF)
Improving Outcomes and Cost of Systemic Sclerosis Related Pulmonary Arterial Hypertension
RECENT SCHOLARLY WORKS
2025
Journal article
The prognostic importance of worsening dyspnoea in systemic sclerosis related interstitial lung disease
DOI: 10.1016/j.semarthrit.2025.1528262025
Journal article
Predicting trajectories of lung function decline in systemic sclerosis-related interstitial lung disease
DOI: 10.1093/rheumatology/keaf2702025
Conference Proceedings
8279516 Autoimmune disease and prevalence of autoantibodies amongst workers exposed to high-dose respirable crystalline silica
DOI: 10.1136/oemed-2025-epicohabstracts.1172025
Journal article
Why is progressive ILD in systemic sclerosis so difficult to predict?
DOI: 10.1016/S2665-9913(25)00068-2